Sameer Khalid Khan

Sameer Khalid Khan

Auto-generated profile, based on publicly available information

Sameer Khalid Khan

Northumbria Healthcare NHS Foundation Trust, Cramlington, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Injury
Verified
Journal Article
Closed access
SKSameer K. Khan
Sameer K. Khan
SKSanjay Kalra
Sanjay Kalra
AKAnil Khanna
Anil Khanna
MTMadhan M. Thiruvengada
Madhan M. Thiruvengada
MPMartyn J. Parker
Martyn J. Parker

31 October 2013 in Acta Orthopaedica
Verified
Journal Article
Open access
SKSameer K Khan
Sameer K Khan
AMAjay Malviya
Ajay Malviya
SMScott D Muller
Scott D Muller
ICIan Carluke
Ian Carluke
PPPaul F Partington
Paul F Partington
MRMike R Reed
Mike R Reed
Enhanced Recovery (ER) is a well-established multidisciplinary strategy in lower limb arthroplasty and was introduced in our department in May 2008. This retrospective study reviews short-term outcomes in a consecutive unselected series of 3,000 procedures (the "ER" group), and compares them to a numerically comparable cohort that had been operated on previously using a traditional protocol (the "Trad" group). Prospectively collected data on surgical endpoints (length of stay (LOS), return to theater (RTT), re-admission, and 30- and 90-day mortality) and medical complications (stroke, gastrointestinal bleeding, myocardial infarction, and pneumonia within 30 days; deep vein thrombosis and pulmonary embolism within 60 days) were compared. Results ER included 1,256 THR patients and 1,744 TKR patients (1,369 THRs and 1,631 TKRs in Trad). The median LOS in the ER group was reduced (3 days vs. 6 days; p = 0.01). Blood transfusion rate was also reduced (7.6% vs. 23%; p < 0.001), as was RTT rate (p = 0.05). The 30-day incidence of myocardial infarction declined (0.4% vs. 0.9%; p = 0.03) while that of stroke, gastrointestinal bleeding, pneumonia, deep vein thrombosis, and pulmonary embolism was not statistically significantly different. Mortality at 30 days and at 90 days was 0.1% and 0.5%, respectively, as compared to 0.5% and 0.8% using the traditional protocol (p = 0.03 and p = 0.1, respectively). This is the largest study of ER arthroplasty, and provides safety data on a consecutive unselected series. The program has achieved a statistically significant reduction in LOS and in cardiac ischemic events for our patients, with a near-significant decrease in return to theater and in mortality rates.

29 June 2015 in British Medical Bulletin
Verified
Journal Article
Open access
PDF file
RCRebecca J. Critchley
Rebecca J. Critchley
SKSameer K. Khan
Sameer K. Khan
AYAlison Yarnall
Alison Yarnall
MPMartyn J. Parker
Martyn J. Parker
DDDavid J. Deehan
David J. Deehan
Hip fractures can be debilitating, especially in patients with pre-existing Parkinson's disease; they have reportedly worse outcomes than non-Parkinson's disease patients. A computerized literature search on PubMed, Medline, Embase, and CINAHL, supplemented by a manual search of related publications. Parkinson's disease patients were found to have significantly lower bone mineral density; higher incidence of falls and hip fractures; delays to receiving their Parkinson's disease medication and surgery; higher risk of pneumonia, urinary infection, pressure sores, post-operative mortality; surgical complications and sequelae, including failed fixation, dislocation, longer hospital stay, re-operation; and increased risk of contralateral hip fracture. Regain of mobility and return to previous residential status have been variably reported. All Parkinson's disease patients should be screened and considered for primary prevention treatment. On admission with hip fractures, attention should be paid to avoid delays to medication, ensuring safe anaesthetic and timely surgery, and post-operative chest physiotherapy and mobilization. Research is needed in minimizing the bone-resorptive effects of anti-Parkinson's disease medication.

3 October 2012 in Age and Ageing
Verified
Journal Article
Open access
PDF file
SKSameer K. Khan
Sameer K. Khan
SRStephen P. Rushton
Stephen P. Rushton
MCMichael Courtney
Michael Courtney
AGAndrew C. Gray
Andrew C. Gray
DDDavid J. Deehan
David J. Deehan
Background: both acute and chronic renal dysfunction (ARD and CRD) have been reported to influence outcomes after neck of femur fractures. We have examined the relationship between the length of stay, mortality and renal dysfunction using biomarkers. These included pre-operative (admission) serum concentrations of urea, creatinine and albumin, and estimated glomerular filtration rates (eGFR) derived from four- and six-variable Modification of Diet in Renal Disease (MDRD) study equations. Methods: complete outcomes data for 566 patients and the patterns of variations in the biomarkers were analysed using generalised linear models. Cox-proportional hazard analyses investigated the association between kidney function (as assessed by the above-mentioned biochemical data) and post-operative length of stay and mortality. All patients were stratified for CRD according to their eGFR. Results: serum urea and creatinine were significantly, positively correlated with age. After adjusting for age and sex, risk of mortality was positively related to six-variable eGFR and creatinine, and marginally so for urea. One-year mortality risk thus worsened with stages of CRD (1–4), increasing age and male gender. Risk of discharge from trauma ward, the length of stay in trauma ward and the overall length of stay were not related to urea and creatinine, but were negatively related to both four- and six-variable eGFR. Conclusions: the study has identified elderly renal-impaired males as the subgroup of patients most at risk for poor survival. This subgroup may require a more targeted approach to the management of their fluid and electrolyte homoeostasis to help improve their outcomes.

1 February 2013 in Journal of Orthopaedic Trauma
Verified
Journal Article
Closed access
SKSameer K. Mrcs Khan
Sameer K. Mrcs Khan
SRSteven P. Ba (Oxon) Rushton
Steven P. Ba (Oxon) Rushton
ADAnis Frcs Dosani
Anis Frcs Dosani
AGAndrew C. Md Gray
Andrew C. Md Gray
DDDavid J. Md Deehan
David J. Md Deehan
Objective: The aim of this study was to investigate factors influencing length of stay and mortality in first and second hip fractures. Design: This was a retrospective study with data analysis. Setting: The study was conducted at a level 1 trauma center. Patients: Six hundred and seventy-two patients treated for hip fractures (OTA 31-A, 31-B, 32-A1.1) over 30 months were split into 2 groups. 1FG: Six hundred and ten patients (90.8%) suffered a fracture for the first time. 2FG: Sixty-two patients (9.2%) had previously sustained contralateral fractures. Intervention: Dynamic hip screws or cephalomedullary nails (31-A fractures); cephalomedullary nails (32-A1.1); dynamic hip screws or cannulated screws (undisplaced 31-B fractures); and hemiarthroplasty (displaced 31-B fractures) were used. Main Outcome Measures: Postoperative lengths of stay on trauma ward (LOS-T) on the rehabilitation unit (LOS-R) and in hospital (LOS-H) were calculated. Dates of death were recorded. Event analysis and structural equation modeling were used to assess the impact of second fractures, fracture types, age, gender, and ASA grades on these. Results: The 2 groups were comparable in gender distribution, ASA grades, fracture types, LOS, and mortality at 120 days. 2FG patients were older than 1FG (mean 83.3 vs 80.2 years) with a higher proportion being discharged to institutional care (35.5% vs 18.5%). Event modeling analysis showed that LOS-T was dependent on ASA grade, whereas mortality was dependent on ASA grade, age, and gender. Second fractures were not related to the risks of increased LOS-T, LOS-R, and mortality. Conclusions: Second fractures per se do not increase the risk of longer postoperative stay or higher mortality. Any observed effect on these outcomes in second fractures represents the influence of increasing age. Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.

1 November 2013 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
PDF file
PMP. D. McGovern
P. D. McGovern
MAM. Albrecht
M. Albrecht
SMS. D. Muller
S. D. Muller
MRM. R. Reed
M. R. Reed
SKS. K. Khan
S. K. Khan